Akari Therapeutics (AKTX) Tax Rate (2025 - 2026)
Akari Therapeutics (AKTX) posted Tax Rate of 5.61% for Q1 2026, up 444.01% sequentially from 1.63% in Q4 2025.
Akari Therapeutics (AKTX) Tax Rate (2025 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has 2 years of Tax Rate data on file, last reported at 5.61% in Q1 2026.
- Quarterly Tax Rate changed N/A year-over-year to 5.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.97% (changed N/A YoY) and the FY2025 annual result came in at 5.48%, changed N/A from the prior year.
- Tax Rate climbed to 5.61% in Q1 2026 per AKTX's latest filing, from 1.63% in the prior quarter.
- The five-year high for Tax Rate was 14.53% in Q3 2025, with the low at 1.63% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | 5.61% |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 12.29% |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 17.68% |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | 9.35% |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 12.51% |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 13.70% |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 7.07% |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Moderna | 28.64 Bn | 23.43 Bn | -566.00 Mn | -0.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.61% |
| Mar 31, 2026 | 5.61% |
| Dec 31, 2025 | -1.63% |
| Dec 31, 2025 | -1.63% |
| Sep 30, 2025 | 14.53% |
| Sep 30, 2025 | 14.53% |